ArticleTranslational oncology2017

Postoperative Adjuvant Sorafenib or Sunitinib for Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus: a Prospective Cohort Study.

Liangyou Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.